Pr Laurent Greillier

Specialty

Oncologist, lung expert

Title

Head of department

Hospital

AP-HM Hôpital Nord (Marseille)

Latest articles

• Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand? (Mar 25, 2025)
• First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018). (Mar 4, 2025)
• [Recommendations for the management of oligometatic NSCLC]. (Mar 1, 2025)
• Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of Immunotherapy. (Dec 9, 2024)
• Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC. (Oct 19, 2024)